
    
      Primary Objective:

      • To quantify the intra-person variability of concentrations of TGF-β1, IL-6, IL-1α, and
      IL-10 measured in exhaled breath condensate.

      Secondary Objectives:

        -  To examine the associations between differences in pre-treatment and post-treatment
           exhaled breath condensate concentrations of TGF-β1, IL-6, IL-1α, and IL-10 and the
           development of CTCAE grade 2+ symptomatic pneumonitis.

        -  To examine the associations between serum measures of TGF-β1, IL-6, IL-1α, and IL-10
           and:

        -  Exhaled breath condensate measures of the same biomarkers, and

        -  The development of CTCAE grade 2+ symptomatic pneumonitis.

        -  To examine the association between microbiome signatures found in pre-treatment exhaled
           breath condensate and the development of CTCAE grade 2+ symptomatic pneumonitis.
    
  